98%
921
2 minutes
20
Objectives: This study aimed to describe the short-term efficacy of sacral neuromodulation (SNM) on cystometric parameters in a population of patients with overactive bladder (OAB) associated with detrusor overactivity (DO).
Materials And Methods: This is a multicenter retrospective study, conducted in three university hospital centers. All patients who underwent two-stage SNM to treat OAB associated with DO between 2016 and 2023 were eligible. Three-day bladder-diary, uroflowmetry, and cystometric parameters were collected at baseline and at the end of the test phase. The primary end point was the disappearance of DO on urodynamic study performed at the end of the test phase. Secondary end points included changes in cystometric parameters, including maximum cystometric capacity (MCC), volume at first sensation of bladder filling (FSBF), volume at first noninhibited detrusor contraction (NIDC), and maximum detrusor pressure (PDetMax). All end points were evaluated in the overall population and in the following subgroups: nonneurogenic and neurogenic populations, nonneurogenic and neurogenic populations with high-pressure DO (PDetMax >40 cmHO).
Results: Among the 97 patients included, 68 (70.1%) were women, and 39 (40.2%) had an underlying neurologic disease. In the overall population, DO disappeared in 18 patients (18.6%), whereas significant increases were observed in the volume at FSBF (+39.5 mL; p = 0.0014) and in MCC (+33.9 mL; p = 0.0021). In the subgroup of patients reporting clinical success and who underwent implantable pulse generator implantation, DO disappeared in 17 patients (20.2%), and improvements in sensory parameters were even more marked (FSBF: +46.9 mL, p < 0.001; MCC: +44.7 mL, p < 0.001). No significant change in PDetMax was observed in either group.
Conclusion: Our study showed that SNM completely eliminated DO in only 18.6% of cases. It also seemed more effective on sensory cystometric parameters (FSBF, MCC) than on motor cystometric parameters (NIDC, PDetMax).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neurom.2025.06.014 | DOI Listing |
J Spinal Cord Med
September 2025
Department of Physical Medicine and Rehabilitation, Ankara City Hospital, Ankara, Turkey.
Context: Individuals with suprasacral spinal cord injury (SCI) often face significant clinical and quality-of-life (QoL) burdens due to neurogenic detrusor overactivity (NDO). Transcutaneous tibial nerve stimulation (TTNS) is a non-invasive neuromodulation technique that may serve as a treatment option, but evidence regarding its effectiveness in anticholinergic-refractory NDO remains limited.
Objectives: To evaluate the effectiveness of TTNS on urodynamic parameters in individuals with SCI who have anticholinergic-refractory NDO.
Neurourol Urodyn
August 2025
Department of Urology, Spinal Injuries Center, Fukuoka, Japan.
Introduction: To compare the efficacy of the β3 agonist vibegron and the anticholinergic agent fesoterodine in the management of neurogenic detrusor overactivity (NDO) in individuals with spinal cord lesion (SCL).
Materials And Methods: This was a single-center, prospective, open-label, randomized, crossover study. A total of 41 individuals with SCL undergoing clean intermittent catheterization, who required pharmacological treatment for NDO confirmed by cystometrogram (CMG), were enrolled in the study.
Neuromodulation
August 2025
Lille Neuroscience and Cognition, Inserm UMR-S1172 LilNCog, University of Lille, Lille, France.
Objectives: This study aimed to describe the short-term efficacy of sacral neuromodulation (SNM) on cystometric parameters in a population of patients with overactive bladder (OAB) associated with detrusor overactivity (DO).
Materials And Methods: This is a multicenter retrospective study, conducted in three university hospital centers. All patients who underwent two-stage SNM to treat OAB associated with DO between 2016 and 2023 were eligible.
Naunyn Schmiedebergs Arch Pharmacol
August 2025
Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
Purpose: Substance P (SP) is important in the physiological and pathophysiological functions of the bladder, including bladder sensory disorders like interstitial cystitis/bladder pain syndrome (IC/BPS) and overactive bladder (OAB). However, the impact of SP on sensory function is not fully understood. The aim of this study was to determine the effects of SP on bladder function in relation to capsaicin, specifically on bladder afferent nerve activity.
View Article and Find Full Text PDFAm J Physiol Regul Integr Comp Physiol
September 2025
Department of Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
This study aimed to investigate the efficacy of different electrical waveforms in suppressing bladder overactivity during acute tibial nerve stimulation (TNS) in cats. Cystometric measurements were performed during intravesical infusion of either acetic acid (AA) or normal saline (NS) control solution. Bipolar hook electrodes were implanted on the left tibial nerve for stimulation.
View Article and Find Full Text PDF